Conquering Chronic Inflammation Today
We have identified a common thread in chronic inflammatory diseases through the use of machine learning and AI-based precision diagnostics.
This work has led to the creation of our patented diagnostic testing and pharmaceutical treatment platform.
.png)
OUR MISSION
Develop solutions for millions of patients suffering from chronic inflammatory diseases worldwide
TODAY: WE ARE DIAGNOSING AND TREATING THESE CHRONIC INFLAMMATORY
DISEASES AND DISORDERS
INCIDENCE OF PREVALENT INFLAMMATORY
DISEASES/DISORDERS IN THE US
LONG COVID
CHRONIC LYME
FIBROMYALGIA
CHRONIC FATIGUE
SYNDROME (ME/CFS)
Tomorrow: Our ongoing research and development includes Oncology, Alzheimer's and Autoimmune Diseases
Executing the same clinical algorithm developed with our machine learning and AI Health Data platform allows us to pursue diagnosis and treatment solutions for many other chronic inflammatory diseases.
.png)
HealthBioAI has cracked the code by identifying the molecular root cause of Long Covid and potentially other inflammatory diseases.
In Long Covid patients, the SI protein of the COVID-19 virus remains in their white blood cells, leading to a persistent immune response despite the absence of the active COVID-19 infection.
These white blood cells have many CCR5 and fractalkine receptors on their cell surface, which promote vascular inflammation and immune dysregulation through the monocytic-endothelial-platelet axis. We believe this is the primary root cause for adverse symptoms.
RESOURCE ARTICLE
Frontiers in Immunology
Persistent of Sars CoV-2 S1 Protein in CD16+ Monocytea in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
.png)
HealthBioAI offers a comprehensive solution for patients suffering from Long Covid.
In today’s healthcare environment, the patient’s journey for diagnoses, treatment, and management of their Long Covid symptoms, can be quite overwhelming. Without a clear root cause of the molecular etiology that can identify and differentiate Long Covid from other inflammatory diseases, the patient is often shuffled from one specialist to another to mitigate their symptoms. HealthBioAI is changing this paradigm by offering a clear, comprehensive path from diagnosis to treatment to management.
1 TELEMED ENGAGEMENT
HealthBioAI’s trained physicians and nurses provide optimal patient engagement via our Patient Concierge Services platform and virtual TeleMed consults.
2 INCELL DX DIAGNOSTICS TEST
Blood-based diagnostic assays (IncellKINE™) differentiate immune-mediated diseases including Long Covid, ME-CFS and chronic Lyme.
4 PATIENT BIOMETRIC MONITORING
Patented biometric wearable helps patients track symptoms to aid in optimizing care.
3 RX THERAPEUTIC INNOVATION
Our patented combination treatment has proven results in mitigating inflammation in immune-mediated diseases. HealthBioAI has a Double-blind, placebo controlled clinical trial accepted by FDA as 505B (2) trial.
Learning algorithms - which have generated new diagnostics,
predictive pathologic processes, and drug discovery.
